Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2005

Primary Completion Date

June 1, 2007

Study Completion Date

June 1, 2007

Conditions

Malignant Melanoma

Interventions

DRUG

CC-5013

Trial Locations (1)

MD Anderson Cancer Center, Houston